VEGFA and amyotrophic lateral sclerosis: The increased serum VEGF-A in our ALS patients is consistent with the existing report [14], and suggests that serum is a pathophysiologically relevant fluid in ALS, particularly in definite ALS, however, a few other studies have failed to observe significant difference in plasma and serum VEGF-A levels in ALS patients [15,16].